Skip to content

Clinical trials

Phase 3 Endometrial Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20071
20092
20131
20151
20182
20191
20211
20222
20231
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Active, not recruiting5
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
AEterna Zentaris1
ARCAGY/ GINECO GROUP1
Advenchen Laboratories, LLC1
BioNTech SE1
Eisai Inc.1
Gilead Sciences1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms24
Ovarian Neoplasms3
Sarcoma3
Uterine Neoplasms3
Neoplasm Metastasis2
Neoplasms2
Sarcoma, Endometrial Stromal2
Uterine Cervical Neoplasms2
Adenocarcinoma1
Carcinoma1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.